相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Germline RUNX1 Intragenic Deletion: Implications for Accurate Diagnosis of FPD/AML
Nicolas Duployez et al.
HEMASPHERE (2019)
Number of RUNX1 mutations, wild-type allele loss and additional mutations impact on prognosis in adult RUNX1-mutated AML
A. Stengel et al.
LEUKEMIA (2018)
Clinical significance of somatic mutation in unexplained blood cytopenia
Luca Malcovati et al.
BLOOD (2017)
Integrating clinical features and genetic lesions in the risk assessment of patients with chronic myelomonocytic leukemia
Chiara Elena et al.
BLOOD (2016)
RUNX1 mutations in acute myeloid leukemia are associated with distinct clinico-pathologic and genetic features (vol 30, pg 2160, 2016)
V. I. Gaidzik et al.
LEUKEMIA (2016)
Cytogenetic and molecular abnormalities in chronic myelomonocytic leukemia
M. M. Patnaik et al.
BLOOD CANCER JOURNAL (2016)
Prognostic interaction between ASXL1 and TET2 mutations in chronic myelomonocytic leukemia
M. M. Patnaik et al.
BLOOD CANCER JOURNAL (2016)
Targeted deep sequencing in polycythemia vera and essential thrombocythemia
Ayalew Tefferi et al.
BLOOD ADVANCES (2016)
Genomic analysis of germ line and somatic variants in familial myelodysplasia/acute myeloid leukemia
Jane E. Churpek et al.
BLOOD (2015)
MDS-associated somatic mutations and clonal hematopoiesis are common in idiopathic cytopenias of undetermined significance
Brian Kwok et al.
BLOOD (2015)
The RUNX1-PU.1 axis in the control of hematopoiesis
Maria Rosaria Imperato et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2015)
Enrichment of FLI1 and RUNX1 mutations in families with excessive bleeding and platelet dense granule secretion defects
Jacqueline Stockley et al.
BLOOD (2013)
Novel RUNX1 mutations in familial platelet disorder with enhanced risk for acute myeloid leukemia: clues for improved identification of the FPD/AML syndrome
M. C. J. Jongmans et al.
LEUKEMIA (2010)
Familial myelodysplasia and acute myeloid leukaemia - a review
Carolyn Owen et al.
BRITISH JOURNAL OF HAEMATOLOGY (2008)
RUNX1 gene mutation in primary myelodysplastic syndrome -: the mutation can be detected early at diagnosis or acquired during disease progression and is associated with poor outcome
Chien-Yuan Chen et al.
BRITISH JOURNAL OF HAEMATOLOGY (2007)